Agenus Inc. is a clinical-stage immuno-oncology biotechnology company focused on the discovery and development of breakthrough treatments that harness the human immune system to fight cancer. Its scientific pipeline specializes in proprietary checkpoint modulators, therapeutic antibodies, and cancer vaccines designed to improve clinical outcomes for oncology patients.